Left Ventricular Remodeling and Myocardial Recovery on Mechanical Circulatory Support

Journal of Cardiac Failure

Volumn 16, Issue 2, 2010, Pages 99-105

  Simon, Marc A ^a   Primack, Brian A ^b   Teuteberg, Jeffrey ^a   Kormos, Robert L ^a   Bermudez, Christian ^a   Toyoda, Yoshiya ^a   Shah, Hemal ^a   Gorcsan III, John ^a   McNamara, Dennis M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy; heart failure; Heart assist device; remodeling

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOMYOPATHY; CONVALESCENCE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXPLANT; FEMALE; HEART ASSIST DEVICE; HEART DILATATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CARDIOMYOPATHIES; COHORT STUDIES; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 75449104811     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.10.018     Document Type: Article

References (34)

1. Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Stevenson L.W., Dembitsky W., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
2. McCarthy P.M., Smedira N.O., Vargo R.L., Goormastic M., Hobbs R.E., Starling R.C., et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 115 (1998) 904-912
3. Frazier O.H., Rose E.A., McCarthy P., Burton N.A., Tector A., Levin H., et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 222 (1995) 327-336
4. Kavarana M.N., Sinha P., Naka Y., Oz M.C., and Edwards N.M. Mechanical support for the failing cardiac allograft: a single-center experience. J Heart Lung Transplant 22 (2003) 542-547
5. Gorcsan III J., Severyn D., Murali S., and Kormos R.L. Non-invasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal. J Heart Lung Transplant 22 (2003) 1304-1313
6. Farrar D.J., Holman W.R., McBride L.R., Kormos R.L., Icenogle T.B., Hendry P.J., et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 21 (2002) 516-521
7. Maybaum S., Stockwell P., Naka Y., Catanese K., Flannery M., Fisher P., et al. Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report. J Heart Lung Transplant 22 (2003) 202-209
8. Khan T., Delgado R.M., Radovancevic B., Torre-Amione G., Abrams J., Miller K., et al. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 22 (2003) 137-146
9. Mancini D.M., Beniaminovitz A., Levin H., Catanese K., Flannery M., DiTullio M., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
10. Hetzer R., Muller J.H., Weng Y., Meyer R., and Dandel M. Bridging-to-recovery. Ann Thorac Surg 71 (2001) S109-S113
11. Frazier O.H., Delgado III R.M., Scroggins N., Odegaard P., and Kar B. Mechanical bridging to improvement in severe acute "nonischemic, nonmyocarditis" heart failure. Congest Heart Fail 10 (2004) 109-113
12. Birks E.J., Tansley P.D., Hardy J., George R.S., Bowles C.T., Burke M., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
13. Bartling B., Milting H., Schumann H., Darmer D., Arusoglu L., Koerner M.M., et al. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 100 19 Suppl (1999) II216-II223
14. Milting H., Bartling B., Schumann H., El-Banayosy A., Wlost S., Ruter F., et al. Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy-first results of the Halle Assist Induced Recovery Study (HAIR). Thorac Cardiovasc Surg 47 (1999) 48-50
15. James K.B., McCarthy P.M., Thomas J.D., Vargo R.L., Hobbs R.E., Sapp S., et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 92 (1995) II191-II195
16. Milting H., El Banayosy A., Kassner A., Fey O., Sarnowski P., Arusoglu L., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transplant 20 (2001) 949-955
17. Terracciano C.M., Hardy J., Birks E.J., Khaghani A., Banner N.R., and Yacoub M.H. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109 (2004) 2263-2265
18. Chaudhary K.W., Rossman E.I., Piacentino III V., Kenessey A., Weber C., Gaughan J.P., et al. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart. J Am Coll Cardiol 44 (2004) 837-845
19. Kucuker S.A., Stetson S.J., Becker K.A., Akgul A., Loebe M., Lafuente J.A., et al. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. J Heart Lung Transplant 23 (2004) 28-35
20. Torre-Amione G., Stetson S.J., Youker K.A., Durand J.B., Radovancevic B., Delgado R.M., et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100 (1999) 1189-1193
21. Goldstein D.J., Moazami N., Seldomridge J.A., Laio H., Ashton Jr. R.C., Naka Y., et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg 63 (1997) 971-974
22. Barbone A., Holmes J.W., Heerdt P.M., The A.H., Naka Y., Joshi N., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 104 (2001) 670-675
23. Bruckner B.A., Stetson S.J., Perez-Verdia A., Youker K.A., Radovancevic B., Connelly J.H., et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20 (2001) 457-464
24. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
25. Simon M.A., Kormos R.L., Murali S., Nair P., Heffernan M., Gorcsan J., et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 112 9 Suppl (2005) I32-I36
26. Potapov E.V., Loforte A., Weng Y., Jurmann M., Pasic M., Drews T., et al. Experience with over 1000 implanted ventricular assist devices. J Card Surg 23 (2008) 185-194
27. Starling R.C., Cooper L.C., Dec G.W., Boehmer J., Liu L., Pauly P., et al. Left ventricular diameter predicts recovery in acute cardiomyopathy: results of the IMAC 2 trial. Circulation 116 16 Suppl (2007) II-671
28. Dandel M., Weng Y., Siniawski H., Potapov E., Lehmkuhl H.B., and Hetzer R. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112 9 Suppl (2005) I37-I45
29. Sheppard R., Bedi M., Kubota T., Semigran M.J., Dec W., Holubkov R., et al. Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. J Am Coll Cardiol 46 (2005) 1036-1042
30. Bedi M.S., Alvarez R.J., Kubota T., Sheppard R., Kormos R.L., Siegenthaler M.P., et al. Myocardial Fas and Cytokine expression in end-stage heart failure: impact of LVAD support. Clin Translational Sci 1 (2008) 245-248
31. Garcia S., Kandar F., Boyle A., Colvin-Adams M., Lliao K., Joyce L., et al. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. J Heart Lung Transplant 27 (2008) 261-267
32. Klotz S., Deng M.C., Stypmann J., Roetker J., Wilhelm M.J., Hammel D., et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg 77 (2004) 143-149 discussion 149-150
33. Haft J., Armstrong W., Dyke D.B., Aaronson K.D., Koelling T.M., Farrar D.J., et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 116 11 Suppl (2007) I8-15
34. Thohan V., Stetson S.J., Nagueh S.F., Rivas-Gotz C., Koerner M.M., Lafuente J.A., et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant 24 (2005) 566-575